rs562219421

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS1

The ENST00000342183.9(NRXN1):​c.81A>G​(p.Ala27Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000263 in 1,382,330 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 1 hom. )

Consequence

NRXN1
ENST00000342183.9 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.329

Publications

0 publications found
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]
NRXN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • chromosome 2p16.3 deletion syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Pitt-Hopkins-like syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autism
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 2-50346869-T-C is Benign according to our data. Variant chr2-50346869-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 378297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.329 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000246 (37/150586) while in subpopulation EAS AF = 0.0063 (32/5082). AF 95% confidence interval is 0.00458. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000342183.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
NM_001330078.2
MANE Select
c.3365-109899A>G
intron
N/ANP_001317007.1
NRXN1
NM_001330092.2
c.81A>Gp.Ala27Ala
synonymous
Exon 1 of 7NP_001317021.1
NRXN1
NM_001330091.2
c.81A>Gp.Ala27Ala
synonymous
Exon 1 of 7NP_001317020.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
ENST00000342183.9
TSL:1
c.81A>Gp.Ala27Ala
synonymous
Exon 1 of 6ENSP00000341184.5
NRXN1
ENST00000401669.7
TSL:5 MANE Select
c.3365-109899A>G
intron
N/AENSP00000385017.2
NRXN1
ENST00000404971.5
TSL:1
c.3485-109899A>G
intron
N/AENSP00000385142.1

Frequencies

GnomAD3 genomes
AF:
0.000246
AC:
37
AN:
150478
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000132
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00628
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000152
AC:
12
AN:
79090
AF XY:
0.000150
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00463
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000265
AC:
326
AN:
1231744
Hom.:
1
Cov.:
30
AF XY:
0.000254
AC XY:
153
AN XY:
603240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
25868
American (AMR)
AF:
0.00
AC:
0
AN:
16502
Ashkenazi Jewish (ASJ)
AF:
0.000203
AC:
4
AN:
19692
East Asian (EAS)
AF:
0.0105
AC:
297
AN:
28198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46468
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39922
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3990
European-Non Finnish (NFE)
AF:
0.0000170
AC:
17
AN:
1001158
Other (OTH)
AF:
0.000160
AC:
8
AN:
49946
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.386
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000246
AC:
37
AN:
150586
Hom.:
0
Cov.:
32
AF XY:
0.000326
AC XY:
24
AN XY:
73558
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41216
American (AMR)
AF:
0.000132
AC:
2
AN:
15132
Ashkenazi Jewish (ASJ)
AF:
0.000290
AC:
1
AN:
3454
East Asian (EAS)
AF:
0.00630
AC:
32
AN:
5082
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10114
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67496
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.000230

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Pitt-Hopkins-like syndrome 2;C3808494:Chromosome 2p16.3 deletion syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
16
DANN
Benign
0.68
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562219421; hg19: chr2-50574007; API